Screening for the optimal induction parameters for periplasmic producing interferon-α2b in Escherichia coli

African Journal of Biotechnology

Volumn 9, Issue 38, 2010, Pages 6345-6354

  Azaman, Siti Nor Ani ^a   Ramanan, Ramakrishnan Nagasundara ^a   Tan, Joo Shun ^a   Rahim, Raha Abdul ^a   Abdullah, Mohd Puad ^a   Ariff, Arbakariya B ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Escherichia coli; Induction parameter; Interferon 2b (IFN 2b); Periplasm; Shake flask culture

Indexed keywords

ALPHA2B INTERFERON; ISOPROPYL THIOGALACTOSIDE;

ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; FERMENTATION; GENE INDUCTION; GROWTH RATE; NONHUMAN; PROCESS OPTIMIZATION; PROMOTER REGION; PROTEIN EXPRESSION; TEMPERATURE;

ESCHERICHIA COLI;

EID: 77957987581     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bäcklund E, Reeks D, Markland K, Weir N, Bowering L, Larsson G (2008). Fedbatch design for periplasmic product retention in Escherichia coli. J. Biotechnol. 135: 358-365.
2. Balagurunathan B, Jayaraman G (2008). Cellular response to accumulation of recombinant proteins in the E. coli inner membrane: Implications for proteolysis and productivity of the secretory expression system. Biochem. Eng. J. 39: 74-83.
3. Barbero JL, Buesa JM, Penalva MA, Perez-aranda A, Garcia JL (1986). Secretion of mature human interferon alpha 2 into the periplasmic space of Escherichia coli. J. Biotechnol. 4: 255-267.
4. Baron E, Narula S (1990). From cloning to a commercial realization: human alpha interferon. Crit. Rev. Biotechnol. 10: 179-190.
5. Billiau A (2006). Interferon: the pathways of discovery I. Molecular and cellular aspects. Cytokine Growth Factor Rev. 17: 381-409.
6. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
7. Bronikowski AM, Bennett AF, Lenski RE (2001). Evolutionary adaptation to temperature. VIII. Effects of temperature on growth rate in natural isolates of Escherichia coli and Salmonella enterica from different thermal environments. Evolution, pp. 33-40.
8. Chelbi-Alix MK, Wietzerbin J (2007). Interferon, a growing cytokine family: 50 years of interferon research. Biochimie, 89: 713-718.
9. Chen H, Morgan JA (2006). High throughput screening of heterologous P450 whole cell activity. Enzyme Microb. Technol. 38: 760-764.
10. Choi JH, Keum KC, Lee SY (2006). Production of recombinant proteins by high cell density culture of Escherichia coli. Chem. Eng. Sci. 61: 876-885.
11. Donovan RS, Robinson CW, Glick BR (1996). Review: Optimizing inducer and culture conditions for expression of foreign proteins under the control of the lac promoter. J. Ind. Microbiol. Biotechnol. 16: 145-154.
12. Gasser B, Saloheimo M, Rinas U, Dragosits M, Rodríguez-Carmona E, Baumann K, Giuliani M, Parrilli E, Branduardi P, Lang C (2008). Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview. Microb. Cell Fact. 7: 11.
13. Ghosalkar A, Sahai V, Srivastava A (2008). Secretory expression of interferon-alpha 2b in recombinant Pichia pastoris using three different secretion signals. Protein Exp. Purif. 60: 103-109.
14. Han MJ, Lee SY (2006). The Escherichia coli proteome: past, present, and future prospects. Microbiol. Mol. Biol. Rev. 70: 362.
15. Hansen LH, Knudsen S, Sørensen SJ (1998). The effect of the lacY gene on the induction of IPTG inducible promoters, studied in Escherichia coli and Pseudomonas fluorescens. Curr. Microbiol. 36: 341-347.
16. Hoffmann F, Heuvel J, Zidek N, Rinas U (2004). Minimizing inclusion body formation during recombinant protein production in Escherichia coli at bench and pilot plant scale. Enzyme Microb. Technol. 34: 235-241.
17. Kopetzki E, Schumacher G, Buckel P (1989). Control of formation of active soluble or inactive insoluble baker's yeast-glucosidase PI in Escherichia coli by induction and growth conditions. Mol. Gen. Genet. 216: 149-155.
18. Mergulhao FJ, Monteiro GA (2007). Analysis of factors affecting the periplasmic production of recombinant proteins in Escherichia coli. J. Mol. Microbiol. Biotechnol. 17: 1236-1241.
19. Mergulhao FJM, Taipa MA, Cabral JMS, Monteiro GA (2004). Evaluation of bottlenecks in proinsulin secretion by Escherichia coli. J. Biotechnol. 109: 31-43.
20. Mergulhao FJM, Summers DK, Monteiro GA (2005). Recombinant protein secretion in Escherichia coli. Biotechnol. Adv. 23: 177-202.
21. Nedwell DB (1999). Effect of low temperature on microbial growth: lowered affinity for substrates limits growth at low temperature. FEMS Microb. Ecol. 30: 101-111.
22. Peng L, Xu Z, Fang X, Wang F, Cen P (2004). High-level expression of soluble human ß-defensin-2 in Escherichia coli. Process Biochem. 39: 2199-2205.
23. Pestka S, Krause CD, Walter MR (2004). Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202: 8-32.
24. Pimienta E, Fando R, Sanchez JC, Vallin C (2002). Secretion of human interferon alpha 2b by Streptomyces lividans. Appl. Microbiol. Biotechnol. 58: 189-194.
25. Ramanan RN, Tey BT, Ling TC, Ariff AB (2009). Classification of pressure range based on the characterization of Escherichia coli cell disruption in high pressure homogenizer. Am. J. Biochem. Biotechnol. 5: 21-29.
26. Ramanan RN, Tik WB, Memari HR, Azaman SNA, Ling TC, Tey BT, Lila MAM, Abdullah MP, Rahim RA, Ariff AB (2010a). Effect of promoter strength and signal sequence on the periplasmic expression on human interferon-a2b in Escherichia coli. Afr. J. Biotechnol. 9:285-292.
27. Ramanan RN, Ling TC, Ariff AB (2010b). A simple method for quantification of interferon-a2b through surface plasmon resonance technique. Afr. J. Biotechnol. 9: 1680-1689.
28. Sandén AM, Prytz I, Tubulekas I, Förberg C, Le H, Hektor A, Neubauer P, Pragai Z, Harwood C, Ward A (2003). Limiting factors in Escherichia coli fed-batch production of recombinant proteins. Biotechnol. Bioeng. 81: 158-166.
29. Schumann W, Ferreira LCS (2004). Production of recombinant proteins in Escherichia coli. Genet. Mol. Biol. 27: 442-453.
30. Somerville JE, Goshorn SC, Fell HP, Darveau RP (1994). Bacterial aspects associated with the expression of a single-chain antibody fragment in Escherichia coli. Appl. Microbiol. Biotechnol. 42: 595-603.
31. Srivastava P, Bhattacharaya P, Pandey G, Mukherjee KJ (2005). Overexpression and purification of recombinant human interferon alpha2b in Escherichia coli. Protein Exp. Purif. 41: 313-322.
32. Terpe K (2006). Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 72: 211-22.
33. Valente CA, Monteiro GA, Cabral JM, Fevereiro M, Prazeres DM (2006). Optimization of the primary recovery of human interferon alpha2b from Escherichia coli inclusion bodies. Protein Exp. Purif. 45: 226-34.
34. Vásquez-Bahena JM, Vega-Estrada J, Santiago-Hernández JA, Ortega-López J, Flores-Cotera LB, Montes-Horcasitas MC, Hidalgo-Lara ME (2006). Expression and improved production of the soluble extracellular invertase from Zymomonas mobilis in Escherichia coli. Enzyme Microb. Technol. 40: 61-66.
35. Weickert MJ, Doherty DH, Best EA, Olins PO (1996). Optimization of heterologous protein production in Escherichia coli. Curr. Opin. Biotechnol. 7: 494-499.
36. Yildir C, Oensan Z, Kirdar B (1998). Optimization of starting time and period of induction and inducer concentration in the production of the restriction enzyme EcoRI from recombinant Escherichia coli 294. Turk. J. Chem. 22: 221-226.